BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Criss CR, Makary MS. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(3): 413-424 [DOI: 10.3748/wjg.v29.i3.413] [Reference Citation Analysis]
2 Lei X, Hu X, Lu Q, Yao Y, Sun W, Ma Q, Huang D, Xu Q. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc. Biochem Biophys Res Commun 2023;638:210-8. [PMID: 36481361 DOI: 10.1016/j.bbrc.2022.11.046] [Reference Citation Analysis]
3 Farzaneh M, Ghasemian M, Ghaedrahmati F, Poodineh J, Najafi S, Masoodi T, Kurniawan D, Uddin S, Azizidoost S. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sci 2022;308:120974. [PMID: 36126725 DOI: 10.1016/j.lfs.2022.120974] [Reference Citation Analysis]
4 da Fonseca LG, Araujo RLC. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World J Gastroenterol 2022; 28(28): 3573-3585 [DOI: 10.3748/wjg.v28.i28.3573] [Reference Citation Analysis]
5 Liu P, Zhang X, Fu Q, Liu C, Luo Q, Yu P, Chen S, Zhang H, Qin T, Zhang Y. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage. Disease Markers 2022;2022:1-10. [DOI: 10.1155/2022/9313680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 De Re V, Rossetto A, Rosignoli A, Muraro E, Racanelli V, Tornesello ML, Zompicchiatti A, Uzzau A. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Front Oncol 2022;12:897703. [DOI: 10.3389/fonc.2022.897703] [Reference Citation Analysis]
7 Kovács A, Bischoff P, Haddad H, Zhou W, Temming S, Schäfer A, Spallek H, Kaupe L, Kovács G, Pinkawa M. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies. JPM 2022;12:430. [DOI: 10.3390/jpm12030430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Li Y, Zhang R, Xu Z, Wang Z. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. IJN 2022;Volume 17:909-25. [DOI: 10.2147/ijn.s349426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]